US Broker Ratings

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A 7.94% Upside Potential in the Healthcare Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is a stalwart in the healthcare sector, specializing in the design, manufacture, and marketing of medical devices. With a market capitalization of $17.67 billion,..

Qiagen N.V. (QGEN) Stock Analysis: Uncovering the Growth Potential in Diagnostics & Research

Qiagen N.V. (QGEN), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is positioned as an intriguing investment opportunity from its base in Venlo, Netherlands...

Roivant Sciences Ltd. (ROIV) Stock Analysis: Navigating Potential Upside with Strong Buy Ratings

Roivant Sciences Ltd. (NASDAQ: ROIV), a burgeoning force in the biotechnology sector, is making waves among investors with its promising pipeline of clinical-stage products. Despite the recent static price movement,..

Smith & Nephew SNATS, Inc. (SNN): Stock Analysis and Investor Outlook with 11.46% Potential Upside

Smith & Nephew SNATS, Inc. (SNN), a stalwart in the healthcare sector, specifically within the medical devices industry, is capturing investor interest with its promising potential upside of 11.46%. As..

Koninklijke Philips N.V. (PHG) Stock Analysis: Unpacking a Potential 27% Upside for Investors

As investors search for stable opportunities in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) emerges as a compelling candidate. With a market capitalization of $25.44 billion, Philips has established..

Amgen Inc. (AMGN) Stock Analysis: Evaluating a Healthcare Powerhouse with Impressive Return on Equity

Amgen Inc. (NASDAQ: AMGN) stands as a titan in the healthcare sector, particularly in the drug manufacturing industry. With a market capitalization of $202.95 billion, Amgen showcases a robust presence..

Novartis AG (NVS) Stock Analysis: Unpacking the Healthcare Giant’s Growth Potential and Dividend Appeal

Novartis AG (NYSE: NVS), a leading player in the healthcare sector, is a Swiss-based pharmaceutical titan renowned for its innovative medicines. With a robust portfolio targeting areas such as oncology,..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 15% Upside Potential

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors. With a market..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 105.67% Potential Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a biotech firm headquartered in Miami, Florida, is capturing investor attention with a promising potential upside of 105.67%. With a market capitalization of $10.9 billion,..

Alcon Inc. (ALC) Stock Analysis: Strong Buy Ratings Signal 28% Potential Upside

Alcon Inc. (NYSE: ALC), a global leader in eye care, has captured investor attention with a robust portfolio and a significant potential upside of 28.58%, based on analyst forecasts. With..

Insmed Incorporated (INSM) Stock Analysis: Biotechnology Giant with 83% Upside Potential

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, has captured investor attention with its considerable market cap of $23.18 billion and a remarkable potential upside of 83.48%...

Incyte Corporation (INCY) Stock Analysis: Navigating a 20.9% Revenue Growth Surge in the Biotech Sector

Investors are increasingly turning their attention to Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology industry with a market capitalization of $23.51 billion. Headquartered in Wilmington, Delaware, Incyte..

Novo Nordisk A/S (NVO) Stock Analysis: Evaluating the 71.4% ROE and Strategic Position in Healthcare

Novo Nordisk A/S (NVO), headquartered in Bagsvaerd, Denmark, is a colossal figure in the healthcare sector, particularly within the Drug Manufacturers – General industry. With a staggering market capitalization of..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Waters Corporation (WAT) Stock Analysis: A Healthcare Giant with a 10% Potential Upside

Waters Corporation (NYSE: WAT), a key player in the healthcare sector, particularly within the diagnostics and research industry, is making waves with its robust financial performance and promising growth outlook...

HCA Healthcare, Inc. (HCA) Investor Outlook: Navigating Potential Upside with a 22.24% Growth Target

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a robust market capitalization of $84.78 billion, it..

Royalty Pharma plc (RPRX) Stock Analysis: Solid Earnings Potential Amidst Growing Biopharma Portfolio

Royalty Pharma plc (NASDAQ: RPRX), a leader in acquiring biopharmaceutical royalties and funding innovation in the healthcare sector, presents an intriguing opportunity for investors seeking exposure to the biotechnology industry...

West Pharmaceutical Services (WST): Analyzing a 22.77% Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) stands out in the healthcare sector, not only for its extensive portfolio of drug containment and delivery systems but also for its promising financial..

Dr. Reddy’s Laboratories Ltd (RDY): Investor Outlook Highlights 13.99% Potential Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a key player in the global pharmaceutical industry, presents an intriguing investment opportunity with a potential upside of 13.99%, according to analyst ratings. As..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unveiling a 30.15% Potential Upside Amid Robust Growth

Investors seeking opportunities in the healthcare sector might find IDEXX Laboratories, Inc. (NASDAQ: IDXX) a compelling choice. With a market capitalization of $42.94 billion, IDEXX stands out as a leader..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds